{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:30:29Z","timestamp":1770903029366,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nefro.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T05:47:06Z","timestamp":1506145626000},"page":"465-477","source":"Crossref","is-referenced-by-count":21,"title":["Gammapat\u00edas monoclonales de significado renal"],"prefix":"10.1016","volume":"37","author":[{"given":"Fernando","family":"Caravaca-Font\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Delgado Lillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2017.03.012_bib0670","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MNH.0000000000000201","article-title":"Spectrum of manifestations of monoclonal gammopathy-associated renal lesions","volume":"25","author":"Sethi","year":"2016","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.1016\/j.nefro.2017.03.012_bib0675","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nefro.2017.03.012_bib0680","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.blre.2015.12.001","article-title":"Monoclonal gammopathy: The good, the bad and the ugly","volume":"30","author":"Glavey","year":"2016","journal-title":"Blood Rev."},{"key":"10.1016\/j.nefro.2017.03.012_bib0685","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"International Kidney and Monoclonal Gammopathy Research Group: Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjh.13620","article-title":"Time to redefine myeloma","volume":"171","author":"Pratt","year":"2015","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0695","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.beha.2005.01.025","article-title":"Monoclonal gammopathies of undetermined significance","volume":"18","author":"Kyle","year":"2005","journal-title":"Best Pract Res Clin Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0700","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0950-3536(05)80258-6","article-title":"Monoclonal gammopathy of undetermined significance (MGUS)","volume":"8","author":"Kyle","year":"1995","journal-title":"Baillieres Clin Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0705","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0710","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.canep.2014.04.006","article-title":"Epidemiology of monoclonal gammopathy of undetermined significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France)","volume":"38","author":"Cabrera","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0715","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2002.03589.x","article-title":"Monoclonal gammopathy in Iceland: A population-based registry and follow-up","volume":"118","author":"Ogmundsd\u00f3ttir","year":"2002","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0720","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/leu.2008.203","article-title":"Pathogenesis and progression of monoclonal gammopathy of undetermined significance","volume":"22","author":"Blad\u00e8","year":"2008","journal-title":"Leukemia."},{"key":"10.1016\/j.nefro.2017.03.012_bib0725","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia."},{"key":"10.1016\/j.nefro.2017.03.012_bib0730","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2141.2007.06873.x","article-title":"Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: Emphasis on risk factors for progression","volume":"139","author":"Kyle","year":"2007","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0735","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","article-title":"Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: A population-based study","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica."},{"key":"10.1016\/j.nefro.2017.03.012_bib0740","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: A retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.nefro.2017.03.012_bib0745","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0046-8177(84)80078-7","article-title":"Light-chain glomerulopathy with amyloid-like deposits","volume":"15","author":"Alpers","year":"1984","journal-title":"Hum Pathol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0750","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0046-8177(85)80017-4","article-title":"Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis","volume":"16","author":"Alpers","year":"1985","journal-title":"Hum Pathol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0755","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJM199106273242603","article-title":"Nephrotoxic potential of Bence Jones proteins","volume":"324","author":"Solomon","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0760","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archinte.1990.00040031693017","article-title":"Renal failure in multiple myeloma pathogenesis and prognostic implications","volume":"150","author":"Alexanian","year":"1990","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0765","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: Reversibility and impact on the prognosis Nordic Myeloma Study Group","volume":"65","author":"Knudsen","year":"2000","journal-title":"Eur J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0770","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1093\/ndt\/gfs449","article-title":"Myeloma kidney: Advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities","volume":"27","author":"Davenport","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib0775","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2215\/CJN.12231212","article-title":"Kidney disease and multiple myeloma","volume":"8","author":"Heher","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0780","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0272-6386(03)00412-8","article-title":"Monoclonal gammopathy: Significance and possible causality in renal disease","volume":"42","author":"Paueksakon","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0785","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Dangerous small B-cell clones","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib0790","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5858\/133.2.249","article-title":"Renal lesions associated with plasma cell dyscrasias: Practical approach to diagnosis, new concepts, and challenges","volume":"133","author":"Herrera","year":"2009","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0795","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"International Kidney and Monoclonal Gammopathy Research Group Monoclonal gammopathy of renal significance: When MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib0800","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAP.0000000000000056","article-title":"Renal involvement in monoclonal gammopathy","volume":"22","author":"Al-Hussain","year":"2015","journal-title":"Adv Anat Pathol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0805","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.ajkd.2015.03.035","article-title":"Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: A case series of 35 patients","volume":"66","author":"Chauvet","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007950100000","article-title":"The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions","volume":"34","author":"Herrera","year":"2001","journal-title":"Med Electron Microsc."},{"key":"10.1016\/j.nefro.2017.03.012_bib0815","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/01913121003672873","article-title":"Ultrastructural immunolabeling in the diagnosis of monoclonal light-and heavy-chain-related renal diseases","volume":"34","author":"Herrera","year":"2010","journal-title":"Ultrastruct Pathol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0820","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2012.108","article-title":"Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0825","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2012.414","article-title":"The diagnosis and characteristics of renal heavy-chain and heavy\/light-chain amyloidosis and their comparison with renal light-chain amyloidosis","volume":"83","author":"Nasr","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0830","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2215\/CJN.07030712","article-title":"Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy","volume":"8","author":"Sethi","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0835","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2013.09.007","article-title":"Membranoproliferative glomerulonephritis: The role for laser microdissection and mass spectrometry","volume":"63","author":"Jain","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0840","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.ki.5001990","article-title":"Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsies","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0845","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2215\/CJN.10641015","article-title":"A patient with abnormal kidney function and a monoclonal light chain in the urine","volume":"11","author":"Leung","year":"2016","journal-title":"Clin J Am Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0850","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","article-title":"Clinicopathologic correlations in multiple myeloma: A case series of 190 patients with kidney biopsies","volume":"59","author":"Nasr","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0855","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ndt\/gfp735","article-title":"Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease","volume":"25","author":"Lorenz","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib0860","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.ajkd.2010.06.018","article-title":"Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma","volume":"56","author":"Qian","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0865","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/snep.2002.33673","article-title":"Kidney and liver involvement in monoclonal light chain disorders","volume":"22","author":"Pozzi","year":"2002","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0870","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5858\/134.4.545","article-title":"Amyloidosis-where are we now and where are we heading","volume":"134","author":"Picken","year":"2010","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0875","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0880","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1182\/blood-2013-01-453001","article-title":"Systemic light chain amyloidosis: An update for treating physicians","volume":"121","author":"Merlini","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib0885","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0890","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: A report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0895","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: Clinicopathologic and proteomic study","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib0900","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: New insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.nefro.2017.03.012_bib0905","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ki.5000123","article-title":"Dysproteinemia, proteinuria, and glomerulonephritis","volume":"69","author":"Nasr","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0910","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1053\/ajkd.2002.36350","article-title":"Renal involvement in monoclonal (type I) cryoglobulinemia: Two cases associated with IgG3 kappa cryoglobulin","volume":"40","author":"Karras","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0915","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.ajkd.2015.08.032","article-title":"Proliferative glomerulonephritis with monoclonal IgG1 deposits in a hepatitis C virus-positive patient","volume":"67","author":"Hemminger","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0920","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.ajkd.2015.11.014","article-title":"Fatal cryocrystalglobulinemia with intravascular and renal tubular crystalline deposits","volume":"67","author":"DeLyria","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0925","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.5858\/arpa.2013-0493-OA","article-title":"Proximal tubulopathies associated with monoclonal light chains: The spectrum of clinicopathologic manifestations and molecular pathogenesis","volume":"138","author":"Herrera","year":"2014","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0930","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","article-title":"Adult Fanconi syndrome secondary to light chain gammopathy clinicopathologic heterogeneity and unusual features in 11 patients","volume":"79","author":"Messiaen","year":"2000","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.nefro.2017.03.012_bib0935","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.ajkd.2004.12.020","article-title":"Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia","volume":"45","author":"Bridoux","year":"2005","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0940","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.ki.5001524","article-title":"Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0945","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","article-title":"Crystal-storing histiocytosis with renal Fanconi syndrome: Pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome","volume":"25","author":"El Hamel","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib0950","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/modpathol.2011.104","article-title":"The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation","volume":"24","author":"Larsen","year":"2011","journal-title":"Mod Pathol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0955","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2014050509","article-title":"Crystalglobulin-induced nephropathy","volume":"26","author":"Gupta","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0960","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/qjmed\/hcu114","article-title":"Crystalglobulinemia syndrome due to monoclonal gammopathy of renal significance","volume":"108","author":"Tsuji","year":"2015","journal-title":"QJM."},{"key":"10.1016\/j.nefro.2017.03.012_bib0965","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5858\/2006-130-165-LATINA","article-title":"Light-chain-mediated acute tubular interstitial nephritis: A poorly recognized pattern of renal disease in patients with plasma cell dyscrasia","volume":"130","author":"Gu","year":"2006","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib0970","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: The disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0975","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/j.ajkd.2003.08.040","article-title":"Light chain deposition disease with renal involvement: Clinical characteristics and prognostic factors","volume":"42","author":"Pozzi","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0980","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: A report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib0985","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis","volume":"65","author":"Nasr","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib0990","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2005.10.023","article-title":"A proliferative glomerulonephritis secondary to a monoclonal IgA","volume":"47","author":"Soares","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib0995","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1000","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5414\/CNP72046","article-title":"Characteristics of proliferative glomerulo-nephritis with monoclonal IgG deposits associated with membranoproliferative features","volume":"72","author":"Masai","year":"2009","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1005","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.10611110","article-title":"Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: Correlation with IgG subclass and response to rituximab","volume":"6","author":"Guiard","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1010","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","article-title":"Monoclonal gammopathy-associated proliferative glomerulonephritis","volume":"88","author":"Sethi","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.nefro.2017.03.012_bib1015","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: A fortuitous association","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: A case series","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1030","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: A unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib1040","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3 targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ki.2013.548","article-title":"Membranous-like glomerulopathy with masked IgG kappa deposits","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib1050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2005.05.004","article-title":"Focal and segmental glomerulosclerosis and plasma cell proliferative disorders","volume":"46","author":"Dingli","year":"2005","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ckj\/sft044","article-title":"Monoclonal gammopathy-associated pauci-immune extracapillary-proliferative glomerulonephritis successfully treated with bortezomib","volume":"6","author":"Grundmann","year":"2013","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefro.2017.03.012_bib1060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.ajkd.2015.10.020","article-title":"Proliferative C4 dense deposit disease, acute thrombotic microangiopathy, a monoclonal gammopathy, and acute kidney failure","volume":"67","author":"Ali","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.ajkd.2015.03.039","article-title":"Distal angiopathy and atypical hemolytic uremic syndrome: Clinical and functional properties of an anti-factor H IgA antibody","volume":"66","author":"Rigothier","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5414\/CN108363","article-title":"Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy","volume":"83","author":"Cheungpasitporn","year":"2015","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5414\/CN107579","article-title":"Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma","volume":"81","author":"Yao","year":"2014","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00296-010-1569-0","article-title":"Renal thrombotic microangiopathies\/thrombotic thrombocytopenic purpura in a patient with primary Sj\u00f6gren's syndrome complicated with IgM monoclonal gammopathy of undetermined significance","volume":"33","author":"Koga","year":"2013","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib1085","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2215\/CJN.02560316","article-title":"Paraprotein\u2013related kidney disease: Kidney injury from paraproteins\u2014what determines the site of injury?","volume":"11","author":"Doshi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2017.03.012_bib1090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1681\/ASN.2007070757","article-title":"Fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"19","author":"Alpers","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1095","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2215\/CJN.02920316","article-title":"Paraprotein\u2013related kidney disease: Diagnosing and treating monoclonal gammopathy of renal significance","volume":"11","author":"Rosner","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2017.03.012_bib1100","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.transproceed.2015.08.023","article-title":"Outcomes of monoclonal gammopathy of undetermined significance in patients who underwent kidney transplantation","volume":"47","author":"Bancu","year":"2015","journal-title":"Transplant Proc."},{"key":"10.1016\/j.nefro.2017.03.012_bib1105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ctr.12595","article-title":"Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance","volume":"29","author":"Goebel","year":"2015","journal-title":"Clin Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib1110","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2017.03.012_bib1130","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1135","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: Definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib1140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Rongioletti","year":"2001","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1515\/cclm-2015-0994","article-title":"Laboratory testing in monoclonal gammopathy of renal significance (MGRS)","volume":"54","author":"Leung","year":"2016","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib1150","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.11161111","article-title":"Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases","volume":"7","author":"Leung","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1155","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4065\/81.12.1575","article-title":"Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays","volume":"81","author":"Katzmann","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.nefro.2017.03.012_bib1160","unstructured":"Rao M, Lamont JL, Chan J, Concannon TW, Comenzo R, Ratichek SJ et al. Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias: Future research needs: Identification of future research needs from comparative effectiveness review N.\u00b0 73. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012. Report N.\u00b0: 12-EHC135-EF. AHRQ Future Research Needs Papers."},{"key":"10.1016\/j.nefro.2017.03.012_bib1165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2013.08.018","article-title":"Serum free light chains in clinical laboratory diagnostics","volume":"427","author":"Jenner","year":"2014","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.nefro.2017.03.012_bib1170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin Chem."},{"key":"10.1016\/j.nefro.2017.03.012_bib1175","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1185","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: Impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1190","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/49.8.1252","article-title":"Practical considerations for the measurement of free light chains in serum","volume":"49","author":"Tate","year":"2003","journal-title":"Clin Chem."},{"key":"10.1016\/j.nefro.2017.03.012_bib1195","doi-asserted-by":"crossref","first-page":"e38061","DOI":"10.1371\/journal.pone.0038061","article-title":"Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (AL)","volume":"7","author":"Ramirez-Alvarado","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.nefro.2017.03.012_bib1200","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"International Kidney and Monoclonal Gammopathy Research Group. How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib1205","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.nefro.2017.03.012_bib1210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ekir.2016.08.012","article-title":"Clinicopathologic features of membranous-like glomerulopathy with masked IgG kappa deposits","volume":"1","author":"Larsen","year":"2016","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.nefro.2017.03.012_bib1215","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-term kidney disease outcomes in fibrillary glomerulonephritis: A case series of 27 patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2017.03.012_bib1220","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2215\/CJN.03160316","article-title":"Bridging the divide: An onco-nephrologic approach to the monoclonal gammopathies of renal significance","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1225","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2215\/CJN.02980316","article-title":"Paraprotein\u2013related kidney disease: Glomerular diseases associated with paraproteinemias","volume":"11","author":"Motwani","year":"2016","journal-title":"Clin J Am Soc Nephro"},{"key":"10.1016\/j.nefro.2017.03.012_bib1230","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood-2006-09-046409","article-title":"Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: A multicenter retrospective study","volume":"109","author":"Chanan-Khan","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib1235","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.leu.2405087","article-title":"Efficacy and safety of bortezomib in patients with renal impairment: Results from the APEX phase 3 study","volume":"22","author":"San-Miguel","year":"2008","journal-title":"Leukemia."},{"key":"10.1016\/j.nefro.2017.03.012_bib1240","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Meister","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.nefro.2017.03.012_bib1245","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood-2008-08-172734","article-title":"The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition","volume":"113","author":"Bianchi","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib1250","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3324\/haematol.11463","article-title":"Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma","volume":"92","author":"Ludwig","year":"2007","journal-title":"Haematologica."},{"key":"10.1016\/j.nefro.2017.03.012_bib1255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1470-2045(11)70081-X","article-title":"Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: A randomised, phase 3, non-inferiority study","volume":"12","author":"Moreau","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1260","first-page":"1287","article-title":"The efficacy and toxicity of bendamustine in recurrent multiple myeloma after high-dose chemotherapy","volume":"90","author":"Knop","year":"2005","journal-title":"Haematologica."},{"key":"10.1016\/j.nefro.2017.03.012_bib1265","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00432-012-1212-4","article-title":"Successful treatment of patients with newly diagnosed\/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone","volume":"138","author":"P\u00f6nisch","year":"2012","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(15)00447-7","article-title":"Bendamustine plus rituximab versus fludarabine plus rituximab for patientswith relapsed indolent and mantle-cell lymphomas: A multicentre, randomised, open-label, non-inferiority phase 3 trial","volume":"17","author":"Rummel","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1275","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2141.2001.03033.x","article-title":"Results of autologous stem cell transplant in multiple myeloma patients with renal failure","volume":"114","author":"Badros","year":"2001","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.22202","article-title":"Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis","volume":"87","author":"Irazabal","year":"2012","journal-title":"Am J Hematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1285","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2014-03-544759","article-title":"How we manage autologous stem cell transplantation for patients with multiple myeloma","volume":"124","author":"Gertz","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2017.03.012_bib1290","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1607751","article-title":"Daratumumab, lenalidomide and dexamethasone for multiple myeloma","volume":"375","author":"Dimopoulos","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2017.03.012_bib1295","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/0091270007309563","article-title":"Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis","volume":"47","author":"Chen","year":"2007","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1300","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2141.2007.06698.x","article-title":"Lenalidomide-induced myelosuppression is associated with renal dysfunction: Adverse events evaluation of treatment-na\u00efve patients undergoing front-line lenalidomide and dexamethasone therapy","volume":"138","author":"Niesvizky","year":"2007","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1305","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfq482","article-title":"Kidney dysfunction during lenalidomide treatment for AL amyloidosis","volume":"26","author":"Specter","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib1310","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2141.2003.04395_2.x","article-title":"Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia","volume":"122","author":"Harris","year":"2003","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1315","first-page":"525","article-title":"Renal involvement in benign monoclonal gammopathies: An underdiagnosed condition","volume":"28","author":"Ramos","year":"2008","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2017.03.012_bib1320","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2215\/CJN.09710913","article-title":"Spanish Group for Study of Glomerular Diseases (GLOSEN) Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2017.03.012_bib1325","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ndt\/gfu306","article-title":"Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus","volume":"30","author":"Caro","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2017.03.012_bib1330","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2015.227","article-title":"Effectiveness of mycophenolate mofetil in C3 glomerulonephritis","volume":"88","author":"Rabasco","year":"2015","journal-title":"Kidney Int."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021169951730070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021169951730070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T08:27:53Z","timestamp":1693038473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021169951730070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S021169951730070X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2017.03.012","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}